Noreen Griffin - Member of 10% owner group, 10%+ Owner at Biostax Corp.

Issuer-level insider activity

Role
Member of 10% owner group, 10%+ Owner
Issuer ticker
IMUN
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Noreen Griffin since 12 Aug 2025

Reported holdings for Noreen Griffin in Biostax Corp.

Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Convertible Note
Shares / value
49,772
Estimated value
Report date
28 May 2021
Price
Ownership
By: Global Reverb Corporation
Underlying class
Common Stock
Underlying amount
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Warrants (Right to Buy)
Shares / value
7,420
Estimated value
Report date
28 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,685
Estimated value
Report date
28 May 2021
Price
Ownership
By: Griffin Family Trust
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Common Stock
Shares / value
704
Estimated value
Report date
28 May 2021
Price
Ownership
By: Griffin Enterprises Group, Inc.
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Common Stock
Shares / value
429
Estimated value
Report date
28 May 2021
Price
Ownership
Direct

Transaction history for Noreen Griffin in Biostax Corp.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .